AF
GRTS

Amalgamated Financial’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Amalgamated Financial’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$21K Buy
+5,144
New +$27.3K ﹤0.01% 2743

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Amalgamated Financial's GRTS Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Gritstone bio, Inc. Common Stock (GRTS) in Q1 2022: 5,144 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #2743 among its holdings.

117 funds tracked by Wall St. Rank hold GRTS as of Q1 2022.

  • Amalgamated Financial held 5,144 shares of Gritstone bio, Inc. Common Stock worth $21K as of Q1 2022.
  • Gritstone bio, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
  • Gritstone bio, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2743 holding.
  • 117 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.